TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
26 hedge funds and large institutions have $40.3M invested in Trillium Therapeutics Inc. in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
75% less call options, than puts
Call options by funds: $3K | Put options by funds: $12K
Holders
26
Holding in Top 10
–
Calls
$3K
Puts
$12K
Top Buyers
| 1 | +$405K | |
| 2 | +$123K | |
| 3 | +$113K | |
| 4 |
SLG
Stanley-Laman Group
Berwyn,
Pennsylvania
|
+$13K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$9.62K |
Top Sellers
| 1 | -$413K | |
| 2 | -$209K | |
| 3 | -$157K | |
| 4 |
Millennium Management
New York
|
-$82K |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$36.6K |